propionamide has been researched along with Disease Models, Animal in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, Y; Gao, L; Hao, C; Jin, J; Liu, BF; Liu, X; Xiong, J; Zhang, G | 1 |
| Filipek, B; Gryboś, A; Karcz, A; Koczurkiewicz, P; Obniska, J; Pękala, E; Rapacz, A; Rybka, S; Siwek, A; Wójcik-Pszczoła, K | 1 |
2 other study(ies) available for propionamide and Disease Models, Animal
| Article | Year |
|---|---|
Piperidine propionamide as a scaffold for potent sigma-1 receptor antagonists and mu opioid receptor agonists for treating neuropathic pain.
Topics: Amides; Animals; Disease Models, Animal; Dose-Response Relationship, Drug; Formaldehyde; Guinea Pigs; Injections, Subcutaneous; Mice; Mice, Inbred ICR; Molecular Structure; Neuralgia; Piperidines; Rats; Rats, Sprague-Dawley; Receptors, Opioid, mu; Receptors, sigma; Sciatic Nerve; Sigma-1 Receptor; Structure-Activity Relationship | 2020 |
Antiallodynic and antihyperalgesic activity of new 3,3-diphenyl-propionamides with anticonvulsant activity in models of pain in mice.
Topics: Amides; Analgesics; Animals; Anticonvulsants; Cell Line, Tumor; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Locomotion; Mice; Microsomes, Liver; Pain Measurement; Piperazines; Radioligand Assay; Serotonin 5-HT1 Receptor Antagonists; Voltage-Gated Sodium Channel Blockers | 2018 |